A Potent Peptidomimetic Inhibitor of Botulinum Neurotoxin Serotype A Has a Very Different Conformation than SNAP-25 Substrate

Adams, 2002, PHENIX: building new software for automated crystallographic structure determination, Acta Crystallogr. D Biol. Crystallogr., 58, 1948, 10.1107/S0907444902016657 Agarwal, 2004, Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212→Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway, Biochemistry, 43, 6637, 10.1021/bi036278w Binz, 2002, Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization, Biochemistry, 41, 1717, 10.1021/bi0157969 Blasi, 1993, Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25, Nature, 365, 160, 10.1038/365160a0 Blasi, 1993, Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin, EMBO J., 12, 4821, 10.1002/j.1460-2075.1993.tb06171.x Boldt, 2006, Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry, Org. Lett., 8, 1729, 10.1021/ol0603211 Breidenbach, 2004, Substrate recognition strategy for botulinum neurotoxin serotype A, Nature, 432, 925, 10.1038/nature03123 Burnett, 2007, Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons, J. Biol. Chem., 282, 5004, 10.1074/jbc.M608166200 Davis, 2007, MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, Nucleic Acids Res., 35, W375, 10.1093/nar/gkm216 Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 Fu, 2006, Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate, Biochemistry, 45, 8903, 10.1021/bi060786z Josko, 2004, Botulin toxin: a weapon in terrorism, Clin. Lab. Sci., 17, 30 Kukreja, 2005, Biologically active novel conformational state of botulinum, the most poisonous poison, J. Biol. Chem., 280, 39346, 10.1074/jbc.M508463200 Kumaran, 2008, Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A, J Biol. Chem., 283, 18883, 10.1074/jbc.M801240200 Lacy, 1998, Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nat. Struct. Biol., 5, 898, 10.1038/2338 Li, 2000, Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain, Biochemistry, 39, 2399, 10.1021/bi992321x McCoy, 2005, Likelihood-enhanced fast translation functions, Acta Crystallogr. D Biol. Crystallogr., 61, 458, 10.1107/S0907444905001617 Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X Rao, 2005, Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies, Curr. Pharm. Des., 11, 295, 10.2174/1381612053382115 Schiavo, 1992, Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin, Nature, 359, 832, 10.1038/359832a0 Schmidt, 1997, Endoproteinase activity of type A botulinum neurotoxin: substrate requirements and activation by serum albumin, J. Protein Chem., 16, 19, 10.1023/A:1026386710428 Schmidt, 1998, Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1′ binding subsite, FEBS Lett., 435, 61, 10.1016/S0014-5793(98)01041-2 Segel, 1975 Silvaggi, 2007, Structures of Clostridium botulinum neurotoxin serotype A light chain complexed with small-molecule inhibitors highlight active-site flexibility, Chem. Biol., 14, 533, 10.1016/j.chembiol.2007.03.014 Silvaggi, 2008, Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex, Biochemistry, 47, 5736, 10.1021/bi8001067 Suzuki, 2005, Non-hydroxamate histone deacetylase inhibitors, Curr. Med. Chem., 12, 2867, 10.2174/092986705774454706 Swaminathan, 2004, Structure and enzymatic activity of botulinum neurotoxins, Mov. Disord., 19, S17, 10.1002/mds.20005